XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity
 3 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Stockholders’ Equity

Note 13 – Stockholders’ Equity

 

Reverse Stock Split

 

On September 9, 2024, the Company’s stockholders approved an amendment to the Company’s articles of incorporation to effectuate a 1-for-2 reverse split of the Company’s common stock. The amendment to the Company’s articles of incorporation was filed with the Nevada Secretary of State on September 9, 2024. The consolidated financial statements, and all share and per share information contained herein, have been retroactively adjusted to reflect the reverse stock split.

 

As of September 30, 2025 and June 30, 2025, the Company had 110,000,000 shares of authorized capital, par value $0.001, of which 100,000,000 shares are designated as common stock, and 10,000,000 shares are designated as preferred stock.

 

Equity Transactions

 

During the three months ended September 30, 2025, 44,357 stock options were exercised at $3.74 per share of common stock.

 

In August 2024, 76,000 stock options were exercised at $0.52 per share of common stock.

 

On September 27, 2024, the Company completed its initial public offering of 2,500,000 shares of common stock, priced at $4.00 per share. Concurrently, the Company issued 2,013 shares as true up shares as a result of the 1-for-2 reverse split. In conjunction with the offering, the Company granted stock purchase warrants to purchase an aggregate of 143,750 shares of its common stock at an exercise price of $4.60 per share to underwriters.

 

During the three months ended December 31, 2024, in connection with the initial public offering, the Company issued 375,000 common shares in respect to the underwriters’ option to purchase up to an additional 375,000 shares of common stock to cover allotments.

 

On December 18, 2024, the Company issued 118,906 common shares pursuant to the terms of the APA.

 

A total of 89,602 stock options were exercised during the year ended June 30, 2025 at $3.74 per share.

 

As of September 30, 2025 and June 30, 2025 the Company had 12,497,027 and 12,452,670 shares of common stock outstanding, respectively, and no shares of preferred stock issued and outstanding.